Navigation Links
Cempra, Inc. to Present at the BioCentury Future Leaders Conference
Date:4/13/2012

CHAPEL HILL, N.C., April 13, 2012 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP) today announced that Prabhavathi Fernandes, Ph.D., president and chief executive officer, will present at the Future Leaders in the Biotechnology Industry conference at 1:30 p.m. EDT, Apr. 20, 2012, at the Millennium Broadway Hotel in New York.  Dr. Fernandes will provide an overview of the company's two leading antibiotic clinical programs, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA™ for the chronic, oral treatment of gram positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.

About Cempra, Inc.
Founded in 2006, Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates have both completed oral Phase 2 clinical trials and seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. The company also intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Additional information about Cempra can be found at www.cempra.com.

Investor Contacts:
Robert E. Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226
Robert.flamm@russopartnersllc.com

Andreas Marathovouniotis
Russo Partners, LLC
(212) 845-4235
Andreas.marathis@russopartnersllc.com

Media Contact:
Elliot Fox                                                                    
Russo Partners, LLC                                                             
(212) 845-4253                                                                      
Elliot.fox@russopartnersllc.com


'/>"/>
SOURCE Cempra, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cempra, Inc. Announces Pricing of Its Initial Public Offering of Common Stock
2. Cempra, Inc. Announces Exercise in Full of Underwriters Option to Purchase Additional Shares
3. Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
11. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
(Date:9/22/2017)... Md. , Sept. 22, 2017  As the ... Republican Senators Bill Cassidy (R-LA) and ... Information notes that the medical device industry is in ... medical device tax, the 2.3% excise tax on medical ... But they also want covered patients, increased visits and ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology:
(Date:9/24/2017)... ... 24, 2017 , ... The Tuscany Resort on Grace Bay in the Turks ... boutique resorts, is planning on re-opening the resort on October 1st. , ... more recently Hurricane Maria, and the staff and landscaping crews were fast in the ...
(Date:9/24/2017)... ... ... The Bible: The Other Sheep”: the ceremonial laws of Moses and the Holy Law of ... of published author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, ... the Seventh-day Adventist Church for many years. He was previously a member of the ...
(Date:9/22/2017)... ... ... On Sunday, September 24, hundreds will gather at Flo Jo Park for ... fastest woman of all time. Flo Jo passed away from complications related to ... Anthem. Mary was a contestant on the 2012 season of America’s Got Talent. ...
(Date:9/22/2017)... West Chester, PA (PRWEB) , ... September 22, ... ... and toddler sleep consulting firm in Pennsylvania, is pleased to offer in-home and ... ever, the effect that sleep deprivation has on the body,” says company owner ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... nutritional supplement produced by Native Remedies that helps promote pancreatic health and ... many individuals. However, some prescription-based approaches can have negative side effects, and with ...
Breaking Medicine News(10 mins):